NUVB – nuvation bio inc. class a (US:NASDAQ)
Stock Stats
News
Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib [Yahoo! Finance]
A Look At Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Licensing Deal [Yahoo! Finance]
Nuvation Bio (NYSE:NUVB) had its price target lowered by analysts at HC Wainwright from $18.00 to $17.00. They now have a "buy" rating on the stock.
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Nuvation Bio says preliminary Q4 and FY25 IBTROZI net product revenue was $15.7M and $24.7M [Seeking Alpha]
Form 8-K Nuvation Bio Inc. For: Jan 11
Form 4 Nuvation Bio Inc. For: Dec 01 Filed by: Liu Dongfang
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Form 4 Nuvation Bio Inc. For: Nov 25 Filed by: Liu Dongfang
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.